Nan Fung Trinity »

Protagonist Therapeutics shares owned by Nan Fung Trinity

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Nan Fung Trinity from 13F filings

Historical chart of Nan Fung Trinity investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Nan Fung Trinity consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Nan Fung Trinity

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.6M 145k 66.43
2025-06-30 $7.5M 135k 55.27

More positions owned by Nan Fung Trinity

Ishares Msci Sth Kor Etf (EWY)
Ishares Msci Brazil Etf (EWZ)
Amcor Ord (AMCR)
Amazon (AMZN)
Spdr Series Trust S&p Regl Bkg (KRE)
Baidu Spon Adr Rep A (BIDU)
NVIDIA Corporation (NVDA)
America Movil Sab De Cv Spon Ads Rp Cl B (AMX)
Intuit (INTU)
PPG Industries (PPG)
Ishares Msci Thailnd Etf (THD)
Zoom Communications Cl A (ZM)
Ishares Tr Core S&p Mcp Etf (IJH)
Ge Healthcare Technologies I Common Stock (GEHC)
Spdr Series Trust S&p Bk Etf (KBE)

View all positions for Nan Fung Trinity

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Rtw Investments
Vanguard Group
State Street Corporation
BVF
Johnson & Johnson
Wellington Management Company
UBS Group
Deep Track Capital
Woodline Partners
Geode Capital Management
Driehaus Capital Management
Henderson Group
Marshall Wace

View all funds holding Protagonist Therapeutics